{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T11:35:29Z","timestamp":1766921729991,"version":"3.33.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Frailty & Aging"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.14283\/jfa.2019.38","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T10:06:03Z","timestamp":1614247563000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association Between the Use of Angiotensin-Blocking Medications with Hip Fracture and Death in Older People"],"prefix":"10.1016","volume":"9","author":[{"given":"C.","family":"Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles D.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14283\/jfa.2019.38_bib1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","article-title":"Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study","volume":"359","author":"Onder","year":"2002","journal-title":"Lance"},{"key":"10.14283\/jfa.2019.38_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1503\/cmaj.061339","article-title":"Effect of perindopril on physical function in elderly people with functional impairment: a randomized control trial","volume":"177","author":"Sumukadas","year":"2007","journal-title":"CMAJ"},{"key":"10.14283\/jfa.2019.38_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jamda.2009.09.014","article-title":"ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study","volume":"11","author":"Cesari","year":"2010","journal-title":"J Am Med Dir Assoc"},{"key":"10.14283\/jfa.2019.38_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ageing\/afx127","article-title":"The effect of perindopril on postural instability in older people with a history of falls\u2014a randomised controlled trial","volume":"47","author":"Sumukadas","year":"2018","journal-title":"Age Ageing"},{"key":"10.14283\/jfa.2019.38_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40266-018-0561-3","article-title":"A systematic Review and meta-analyses of the association between anti-hypertensive classes and the risk of falls among older adults","volume":"35","author":"Ang","year":"2018","journal-title":"Drugs Aging"},{"key":"10.14283\/jfa.2019.38_bib6","doi-asserted-by":"crossref","first-page":"e009522","DOI":"10.1136\/bmjopen-2015-009522","article-title":"Danish register-based study on the association between specific cardiovascular drugs and fragility fractures","volume":"5","author":"Torstensson","year":"2015","journal-title":"BMJ Open"},{"key":"10.14283\/jfa.2019.38_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J Hypertens"},{"key":"10.14283\/jfa.2019.38_bib8","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jbmr.2271","article-title":"Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly","volume":"29","author":"Butt","year":"2014","journal-title":"J Bone Mineral Res"},{"key":"10.14283\/jfa.2019.38_bib9","first-page":"57","article-title":"ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men","volume":"46","author":"Kwok","year":"2017","journal-title":"Age Ageing"},{"key":"10.14283\/jfa.2019.38_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","article-title":"Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study","volume":"15","author":"Ruths","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.14283\/jfa.2019.38_bib11","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.4103\/0366-6999.195472","article-title":"Long-term effects of antihypertensive drug use and new-onset osteoporotic fracture in elderly patients: a population-based longitudinal cohort study","volume":"129","author":"Chen","year":"2016","journal-title":"Chin Med J"},{"key":"10.14283\/jfa.2019.38_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"Risk of fractures in older adults using antihypertensive medication","volume":"26","author":"Solomon","year":"2011","journal-title":"J Bone Mineral Res"},{"key":"10.14283\/jfa.2019.38_bib13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12020-016-1201-5","article-title":"ACE inhibitors and the risk of fractures: a meta-analysis of observational studies","volume":"55","author":"Cheng","year":"2017","journal-title":"Endocrine"},{"key":"10.14283\/jfa.2019.38_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2016.01.003","article-title":"Association between allopurinol use and hip fracture in older patients","volume":"84","author":"Basu","year":"2016","journal-title":"Bone"},{"key":"10.14283\/jfa.2019.38_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statistical Assoc"},{"key":"10.14283\/jfa.2019.38_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ageing\/afq071","article-title":"The effect of treatment based on a diuretic (indapamide) \u00b1 ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET)","volume":"39","author":"Peters","year":"2010","journal-title":"Age Ageing"},{"key":"10.14283\/jfa.2019.38_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-017-0888-0","article-title":"The impact of antihypertensive medications on bone mineral density and fracture risk","volume":"19","author":"Barzilay","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.14283\/jfa.2019.38_bib18","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00198-019-05041-3","article-title":"The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative","volume":"30","author":"Carbone","year":"2019","journal-title":"Osteoporosis International"},{"key":"10.14283\/jfa.2019.38_bib19","first-page":"168","article-title":"New Horizons in orthostatic hypotension","volume":"46","author":"Frith","year":"2017","journal-title":"Age Ageing"},{"key":"10.14283\/jfa.2019.38_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11906-011-0207-x","article-title":"Effects of antihypertensive treatment on endothelial function","volume":"13","author":"Virdis","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.14283\/jfa.2019.38_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jash.2013.09.001","article-title":"Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness","volume":"8","author":"Koumaras","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.14283\/jfa.2019.38_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00198-015-3332-6","article-title":"Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study","volume":"27","author":"Solomon","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.14283\/jfa.2019.38_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11657-017-0387-3","article-title":"Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men","volume":"12","author":"Rianon","year":"2017","journal-title":"Arch Osteoporos"}],"container-title":["The Journal of Frailty & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124002718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124002718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:06:18Z","timestamp":1737338778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2260134124002718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2260134124002718"],"URL":"https:\/\/doi.org\/10.14283\/jfa.2019.38","relation":{},"ISSN":["2260-1341"],"issn-type":[{"type":"print","value":"2260-1341"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between the Use of Angiotensin-Blocking Medications with Hip Fracture and Death in Older People","name":"articletitle","label":"Article Title"},{"value":"The Journal of Frailty & Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jfa.2019.38","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}